Jeff Danis has a Bachelor's degree in Biology from Boston College. With over two decades of experience in the pharmaceutical industry, Jeff has held various roles in clinical operations at companies such as Miltenyi Biomedicine, Shire, Catabasis Pharmaceuticals, Inc., FORUM Pharmaceuticals, Ironwood Pharmaceuticals, Inc., Millennium Pharmaceuticals, and Invitrogen. Currently serving as the Director of Clinical Operations at Miltenyi Biomedicine, Jeff has a strong background in managing clinical trials and ensuring operational efficiency in the field.
January, 2022 - present
Director, Clinical Operations at Arrivo BioVentures
Director, Clinical Operations at Kedalion Therapeutics
Director, Clinical Operations at Excision BioTherapeutics
Director, Clinical Operations at Immunexpress
Director, Clinical Operations at Acumen Pharmaceuticals